The Public Procurement Monitoring Office (PPMO) has blacklisted two foreign construction companies and one Nepali firm for failing to comply with procurement regulations.In a decision made on Monday, ...

In a strategic move, Sarepta recently announced the discontinuation of its SRP-5051 (PPMO) program due to risk-benefit concerns, FDA feedback, and an evolving therapeutic landscape. While this ...

Then provide the details of the contract. Documents will be created in the 'SOURCE' sub-directory of the corresponding project directory. termux-setup-storage echo ...

However, Baird expressed some disappointment due to Sarepta's decision to discontinue its PPMO (Peptide-conjugated Phosphorodiamidate Morpholino Oligomer) program. The termination of this program has ...

Alongside the earnings release, Sarepta also announced its decision to discontinue its entire PPMO program, which also includes the investigational exon 51 skipping DMD candidate SRP-5051.

However, Baird expressed some disappointment due to Sarepta's decision to discontinue its PPMO (Peptide-conjugated Phosphorodiamidate Morpholino Oligomer) program. The termination of this program ...

Sarepta Therapeutics SRPT posted third-quarter 2024 adjusted earnings per share (EPS) of 62 cents, which beat the Zacks Consensus Estimate of a loss of 15 cents. Earnings rose 99% year over year ...

The safety signal deprived Sarepta of a near-term shot at accelerated approval—and took down the biotech’s entire PPMO franchise. However, Sarepta gave up on the program Wednesday. Louise ...

Before I discuss our progress, let me discuss our PPMO program. You will have seen in our release that we have made the decision to discontinue the SRP-5051 development program. This was done ...